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Abstract
Background
Atopic dermatitis (AD) is known to predate asthma and other atopic disorders described
under the term “atopic march”. However, this classic sequence is not always present and
only a few studies have addressed children at risk of developing asthma. The objective of
this study is to define early-onset AD phenotypes leading to asthma.
Methods
We performed a cluster analysis with 9 variables of 214 infants with early-onset AD pro-
spectively enrolled in the ORCA cohort and followed each year on the occurrence of asthma
until the age of 6.
Results
We identified 3 clusters - cluster 1 (n = 94) with low to no sensitization to food (27.7%) or
aeroallergens (10.6%) and moderate AD severity (SCORAD 25.29 +/- 14.6) called “AD with
low sensitization”; - cluster 2 (n = 84) characterized by a higher AD severity (SCORAD
32.66+/-16.6) and frequent sensitization to food (98.9%) or aeroallergens (26.2%), most
likely multiple (96.4% for food allergens), called “AD with multiple sensitizations” - cluster 3
(n = 36) with parental history, moderate AD severity (SCORAD 24.46+/-15.7), moderate
rate of sensitization to food allergens (38.9%) (exclusively single) with no sensitization to
aeroallergens, called “AD with familial history of asthma”. Percentages of children suffering
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from asthma at the age of 6 were higher in clusters 2 and 3 (36.1% and 33.3% respectively
versus 14.9% in cluster 1, p<0.01).
Conclusion
Two phenotypes in infants with early-onset AD convey a higher risk of developing asthma
during childhood: multiple sensitization and familial history of asthma.
Introduction
Atopic dermatitis (AD) has become a significant public health problem because of its increas-
ing prevalence [1]. The relationship between AD and sensitization to aeroallergens has been
previously described [2]. This progression from AD to sensitization to aeroallergens and then
asthma may be defined as the natural history of atopic manifestations, described by the term
“atopic march”. Atopic march is characterized by a sequence of atopic diseases in childhood,
typically with AD predating the development of other allergic disorders later in life. It has been
estimated that one-third to half of patients with AD will develop asthma [3]. However, debate
continues as to whether this represents a causal relationship as the atopic march does not
always follow this classic sequence. Although AD seems to be the first step leading to asthma
especially when severe [4, 5] or early-onset [6], most studies performed on atopic march mech-
anisms have focused on birth cohorts or in the general population where this phenotype is
quite rare [7, 8].
In this context, we set out to define phenotypes of early-onset AD leading to asthma in a
prospective study using an unsupervised statistical approach. Because the mechanisms of pro-
gression from AD to asthma seem to be a combination of shared environmental factors and
genetic background [9], analysis included environmental factors, familial history and biological
markers of atopy.
Patients and Methods
Design and inclusion criteria
Patients were part of the ten-year (2002–2012) Observatory of Respiratory risks linked with
Cutaneous Atopy (ORCA) study, resulting from the collaboration between two tertiary care
centers, the Allergology Department at the Armand Trousseau Children’s Hospital and the
Dermatology Department at the Saint-Louis Hospital, both in Paris, France. The study pro-
spectively included children with early-onset AD living in Paris or its suburbs and referred to
the Saint-Louis Hospital by a primary care physician. All the children meeting the following
criteria were considered for inclusion: i. aged younger than 12 months, ii. with an active AD
diagnosed by a dermatologist according to the United KingdomWorking Party criteria
(UKWP) [10] and ISAAC questionnaire [11], iii. without any history of wheezing before the
time of inclusion. It was offered to parents who entered the study to follow their child with a
systematical reevaluation on atopic dermatitis, allergic and asthma status annually until the age
of 6 years.
Ethics
Both parents of each child provided written informed consent at inclusion. The study was spe-
cifically approved by the Institutional Review Board of the Medical Ethics Committee on
Atopic Dermatitis Phenotypes at Risk of Asthma
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Research of the Saint-Louis Hospital (Comité Consultatif de Protection des Personnes dans la
Recherche Biomédicale, Hôpital Saint Louis, Paris France) in September 2001 under the ID
number 2001/42. Data were collected for the study with respect to the confidentiality of patient
records.
Data collection at inclusion
Clinical data collected by a trained study binomial, including a dermatologist and an allergo-
pulmonologist,were:
1. Age and gender.
2. Ethnic background (categorized as of Western Europe descent, African-Caribbean descent
and other descent) and socio-economic status based on the highest level of occupation of
the parents, categorized as low (low-level white-collar workers, blue-collar workers, and the
unemployed), intermediate (intermediate white-collar workers, craftsmen, and shopkeep-
ers) or high (high-level white-collar workers) [12].
3. AD severity was assessed by the auto-administered and physician-supervised objective
SCORAD questionnaire [13]. We considered severity as mild when the SCORAD was
under 15, moderate when the SCORAD was between 15 and 40 as high when the SCORAD
was above 40 [14].
4. Food allergy was defined by relevant allergic symptoms (such as urticaria, difficulties to
breathe, gastro-intestinal disorders), assessed by a structured questionnaire, following con-
sumption of a food allergen and associated with an IgE sensitization to the same allergen,
and was confirmed by the allergo-pulmonologist. Cow’s milk allergy was analyzed sepa-
rately from other food allergies due to its particular good prognosis during childhood [15].
5. Finally, parental history of asthma.
Environmental factors were evaluated by questionnaire and included potential sources of
biologic allergens in the household environment: presence of molds (reported visible molds,
moldy smell, or both), furred pets (cats, dogs, and rodents) or cockroaches in the home [12].
Behavioral factors assessed included postnatal exposure to tobacco smoke (based on smokers
in the home including mother, father, or other adult household members) and day care atten-
dance during the first year of life [12].
Biological markers of atopy were measured in peripheral blood. These included IgEs for spe-
cific aeroallergens and food allergens (ImmunoCAP Phadiatop Infant; Phadia AB-Thermo
Fisher Scientific; Uppsala, Sweden), less-specific markers such as blood eosinophilia (cell
counting by automated Sysmex; Roissy, France) and total IgE (measured by ImmunoCAP
Total IgE;; Phadia AB-Thermo Fisher Scientific; Uppsala, Sweden).
Thresholds were used to define increased levels, according to previous studies: increased
blood eosinophilia was defined as a concentration of 470 eosinophils/mm3 or more and
increased total IgE as a concentration of 45 kU/L or more [2, 16].
Sensitization was defined as a specific IgE concentration0.35 kU/L in serum against one
of the following aeroallergens and food allergens: house dust mite (HDM), cat and dog dander,
pollens (birch tree, timothy grass, mugwort), cockroaches, cow's milk, hen’s egg, peanut, soy,
fish and wheat.
Multiple sensitizations were defined as at least two positive specific IgEs to allergens [2].
Atopic Dermatitis Phenotypes at Risk of Asthma
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Prospective data collection
Children were followed-up annually both by a dermatologist and an allergo-pulmonologist
annually from the age of 6 months until the age of 6 years.
Parameters recorded at each visit were:
1. Active AD during the year, assessed by the dermatologist using SCORAD and topical corti-
costeroid use. Remission of AD was defined as the absence of active AD during the year
before the visit (SCORAD equal to zero and absence of topical corticosteroid use)
2. Occurrence of food allergy as defined at the time of inclusion, confirmed by the allergo-
pulmonologist
3. Biological markers of atopy (i.e. IgEs for specific aeroallergens and food allergens, total IgE
and blood eosinophilia, using the same thresholds as at the time of inclusion)
4. Respiratory outcome defined according to parents’ answers to ISAAC questionnaire admin-
istered during the visit [11] and collected by the allergo-pulmonologist. Briefly, diagnosis of
asthma was considered if parents answered “yes” to one or more of the following questions:
“has your child ever had a medical diagnosis of asthma?”, “in the last 12 months, has your
child’s chest sounded wheezy during or after exercise?”, “in the last 12 months, has your
child had a dry cough at night, apart from a cough associated with a cold or a chest infec-
tion? “; or if parents answered “three times or more” to the question “has your child ever
had wheezing or whistling in the chest at any time in the past?”[17]. Allergic asthma was
defined by symptoms of asthma associated with an IgE sensitization to one or more
aeroallergens.
Dataset about the cohort is avalaible in the Supporting Information file (S1 File)
Statistics
According to the prevalence of asthma in 6-year-old children with AD [3] and studied risk fac-
tors, it was estimated that 246 subjects would be required to show a significant difference of
0.05 between groups.
Variable reduction and data transformation. The initial database included 36 variables.
A reduction was required to perform the cluster analysis. Variables that were clinically redun-
dant were excluded or reduced to avoid bias in the cluster analysis (such as topical corticoste-
roid use and SCORAD to evaluate disease severity, percentage along with absolute number of
eosinophils, or multiple sensitizations to allergens along with sensitization to allergens taken
individually). Environmental parameters were not included in the cluster analysis but were
crossed with the final clusters. Subjects were required to have a full data set of the variables
used in the cluster analysis: demographic data, variables previously reported to affect disease
severity, biological markers of atopy
Statistical analysis. Statistical analysis was performed with R version 2.12.0 (http://www.
r-project.org). A hierarchical bottom-up clustering method was used to perform an unsuper-
vised classification of the population [18]. This agglomerative approach begins with each sub-
ject as a separate cluster and merges them into successively larger clusters. Ward’s linkage
(sample merged into larger clusters to minimize the within-cluster sum of squares) and the
Euclidian distance were considered (R package, cluster). Before hierarchical clustering analysis,
a dissimilarity matrix needs to be evaluated. All variables are standardized to give them the
same weight in the analysis. Gower’s standardization was applied for this [19]. The dendro-
gram provided by the method helps to identify the number of clusters since it gives information
on the cost of merging clusters. A classification into 2 groups was suggested but discarded
Atopic Dermatitis Phenotypes at Risk of Asthma
PLOSONE | DOI:10.1371/journal.pone.0131369 June 24, 2015 4 / 14
because it only reflected one dimension, the AD outcome. No clear indication was given for the
choice between 3, 4 or 5 groups. However, we discarded classification into 4 or 5 groups
because the subgroups were too small and the interpretation complex and lacking in clarity.
Finally a classification into 3 clusters that met relevance and statistical requirements was cho-
sen. The cluster stability was evaluated by altering the initial sample. To determine significant
differences between clusters, analysis of variance and the Kruskal-Wallis test were used for con-
tinuous variables (i.e. SCORAD and biological parameters such as serum total IgE and blood
eosinophilia); Chi-2 test and Fischer's exact test were used for categorical variables. In a second
step, a decision tree was constructed by using the classification and regression trees method
[19]. The aim was to predict the cluster label based on a list of variables used for the cluster
analysis (R package, Rpart). The trees were pruned to minimize the cross-validated error. The
random forest method [20], which consists in aggregating many decision trees, was also used
(R package, random forest). This method, which is based on re-sampling techniques, is more
stable and can be used to determine which variables are important in the classification.
Results
271 consecutive children consulting as outpatients for ADmanagement were included in the
study. Forty-two were lost to follow-up immediately after the inclusion visit and were not
included in the analysis. Fifteen subjects had missing data for the variables used in the cluster
analysis. The remaining 214 patients were included in the analysis. The baseline characteristics
of the children not included in the final analysis did not differ from those of the final sample in
terms of age, gender, SCORAD, parental history of asthma, food allergy and environmental
factors at the time of inclusion.
Descriptive data at inclusion
Mean age (+/- SD) was 8.51 +/- 2.79 months, 124 (57.9%) were boys, mean SCORAD (+/- SD)
was 28.04 +/- 16, and 25 (11.7%) had a documented history of food allergy. Mean serum total
IgE level (+/- SD) was 114.6 +/- 322.7 kU/L and mean blood eosinophilia (+/- SD) was 354 +/-
543/mm3. 123 (57.5%) children were sensitized to food allergens and 32 (14.9%) to aeroaller-
gens. Results concerning the cohort are summarized in Tables 1 and 2.
AD phenotypes at the time of inclusion, based on cluster analysis
A hierarchical clustering approach was used to generate a classification that revealed 3 clusters
of children with shared phenotypes (Fig 1). These clusters were identified using the 9 following
variables: sex, history of parental asthma, severity of AD based on SCORAD, cow’s milk allergy,
food allergy, serum total IgE, blood eosinophilia, sensitization to food allergens and
aeroallergens.
Cluster 1. Cluster 1 comprised 94 children, aged (mean +/- SD) 8.08+/- 2.92 months.
Sixty (63.8%) were boys. In this cluster, AD severity was moderate (mean SCORAD +/- SD
25.29 +/- 14.6) and a parental history of asthma was reported for one patient only (1.1%). Food
allergy was also rare (n = 1, 1.1%). None of the children was reported to have cow’s milk
allergy. Sensitization to allergens was infrequent (n = 26, 27.7% to food allergens, with 2.3%
multiple food sensitizations and n = 10, 10.6% to aeroallergens with 1.1% multiple aeroallergen
sensitizations). Blood eosinophilia (mean+/- SD) was 242.5+/-285.1/mm3 and total IgE level
(mean+/-SD) was 34.8 +/- 86.6 kU/L. We called this cluster “AD with low sensitization”.
Cluster 2. Cluster 2 comprised 84 children, aged (mean +/- SD) 8.76+/- 2.5 months. Most
of them (56%) were boys. This cluster had the highest AD severity (mean SCORAD +/- SD
32.66+/-16.6). Cow’s milk allergy was reported exclusively in this cluster (n = 12, 14.3%) and
Atopic Dermatitis Phenotypes at Risk of Asthma
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food allergy was also most frequent (n = 18, 21.4%) and frequently multiple (n = 7, 38.9%). A
parental history of asthma was reported for 36 patients (42.9%). This cluster also had the high-
est total IgE level (mean +/- SD, 241.8+/- 482.9 kU/L) and the highest blood eosinophilia
(mean +/- SD 554.9+/- 760.9/mm3). Sensitization to food allergens was most frequent (n = 83,
98.9%) with 81 children with multiple food sensitizations (96.4%). Sensitization to aeroaller-
gens was more frequent in this cluster compared to the others (n = 32, 26.2%, with 7.1% multi-
ple sensitized). We called this cluster “AD with multiple sensitizations”.
Cluster 3. Cluster 3 comprised 36 children, aged (mean+/- SD) 9.09+/-2.96 months. It
included more girls than the other clusters (n = 18, 50%). AD severity was moderate (mean
SCORAD +/- SD, 24.46+/-15.7). All children in this cluster had a parental history of asthma.
Food allergy was lower than in cluster 2 (n = 1, 2.8%) and also exclusively single. None of the
children had cow’s milk allergy. Sensitization to food allergen was present in 38.9% (n = 14)
and was exclusively single. None of the children were sensitized to aeroallergens. Mean levels
of total IgE and blood eosinophilia were the lowest in this cluster, values were (+/- SD) 31.3+/-
44.3 kU/L for IgE and 186.2+/-248.4/mm3 for blood eosinophilia. We called this cluster “AD
with familial history of asthma”.
Table 1. Clinical parameters at inclusion in the entire cohort and according to cluster analysis.
Parameters Entire cohort
n = 214
Cluster 1AD1 with LS2
n = 94
Cluster 2AD with MS3
n = 84
Cluster 3AD with FHA4
n = 36
p-
value6
Age (months), mean +/- SD5 8.51 +/- 2.79 8.08 +/- 2.92 8.76 +/- 2.50 9.09 +/- 2.96 0.13
Male sex 57.9 63.8 56 50 0.30
SCORAD, mean +/- SD 28.04 +/-16 25.29 +/- 14.6 32.66 +/- 16.6 24.46 +/- 15.7 <0.01
Parental history of asthma 34.1 1.1 42.9 100 <0.001
Documented history of food
allergy
11.7 1.1 21.4 2.3 <0.001
Cow’s milk allergy 5.6 0 14.3 0 <0.001
Multiple food allergy 3.3 0 8.3 0 <0.01
Exposure to tobacco smoke 36 27.7 41.7 44.4 0.07
Day care attendance 51.9 53.2 48.8 55.6 0.75
Socio-economic status: 0.5
High 37 39.6 39.2 24.2
Intermediate 37 37.4 32.9 45.5
Low 26.1 23.1 27.9 30.3
Furred pet at home 22 16 29.8 19.4 0.07
Ethnic background: 0.11
Western Europedescent 48 37.3 50.8 64.5
AfricanCaribbean descent 23.4 29.9 24.6 12.9
- Other descent 28.7 33 24.6 22.6
All values for categorial or qualitative variables given as percentages. Boldfaced text indicates statistical signiﬁcance.
1AD = atopic dermatitis
2LS = low sensitization
3MS = multiple sensitizations
4FHA = familial history of asthma.
5SD = standard deviation
6Analysis of variance and Chi-2 test when conditions allowed, Kruskal-Wallis and Fischer's exact test otherwise.
doi:10.1371/journal.pone.0131369.t001
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Progression by the end of the follow-up
At the age of 6 years, 54 children (26.6%) had developed asthma. Forty-five of these (83.3%)
had allergic asthma. No significant relationship was found between persistence of AD and
asthma outcome at the age of 6. There were significantly higher percentages of children suffer-
ing from asthma at the age of 6 in clusters 2 and 3 compared to cluster 1 (respectively 36.1%
and 33.3% versus 14.9%, p<0.01) and more cases of allergic asthma in these clusters (30.5 and
27.3% in clusters 2 and 3 respectively compared to 12.6% in cluster 1, p = 0.01). There was a
trend towards a greater percentage of remission of AD in clusters 3 and 1, compared to cluster
2 (respectively 64.7 and 47.1% versus 40.5%, p = 0.06). The fact that the results persisted over
Table 2. Biological parameters at inclusion in the entire cohort and according to cluster analysis.
Parameters Entire cohort Cluster 1 AD1 with
LS2
Cluster 2AD with
MS3
Cluster 3 AD with
FHA4
p-
value6
n = 214 n = 94 n = 84 n = 36
Total serum IgE level (kU/L), mean +/- SD5 114.6 +/-
322.7
34.8 +/- 86.6 241.8 +/- 482.9 31.3 +/- 44.3 <0.001
Blood eosinophilia (cells count/mm3), mean +/-
SD
354 +/- 543 242.5 +/- 285.1 554.9 +/- 760.9 186.2 +/- 248.4 <0.001
Sensitization to food allergen 57.5 27.7 98.9 38.9 <0.001
Multiple sensitizations to food allergens 38.8 2.3 96.4 0 <0.001
Sensitization to hen’s egg 54.2 28.7 86.9 44.4 <0.001
IgE level (kU/L), mean +/- SD 6.6 +/- 15.2 1.9 +/- 5.9 14 +/- 21.4 1.5 +/- 3.6 <0.001
Sensitization to cow’s milk 49.1 5.3 72.6 8.3 <0.001
IgE level (kU/L), mean +/- SD 1.5 +/- 4.9 0.1 +/- 0.6 3.7 +/- 7.2 0.2 +/- 0.9 <0.001
Sensitization to peanut 30.8 5.3 70.2 5.6 <0.001
IgE level (kU/L), mean +/- SD 3.2 +/- 12.8 0.2 +/- 1.4 7.8 +/- 19.5 0.1 +/- 0.3 <0.001
Sensitization to white ﬁsh 1.9 0 4.8 0 0.04
IgE level (kU/L), mean +/- SD 0.8 +/- 0.7 - 0.2 +/- 0.1 - 0.2
Sensitization to wheat 3.7 1.1 8.3 0 0.02
IgE level (kU/L), mean +/- SD 0.2 +/- 1.8 0 +/- 0.4 0.5 +/- 2.8 - 0.015
Sensitization to aeroallergens 14.9 10.6 26.2 0 <0.01
Multiple sensitizations to aeroallergens 3.3 1.1 7.1 0 <0.01
Sensitization to HDM 3.3 3.2 3.6 2.8 0.97
IgE level (kU/L), mean +/- SD 0.2 +/- 1.3 0.29 +/6 1.8 0.09 +/- 0.55 0.04 +/- 0.3 0.82
Sensitization to cat dander 12.6 8.5 22.6 0 <0.001
IgE level (kU/L), mean +/- SD 0.8 +/- 6.9 0.1 +/- 0.4 1.9 +/- 1.1 - <0.001
Sensitization to pollens 2.3 0 5.9 0 0.02
IgE level (kU/L), mean +/- SD 0.01 +/- 0.1 - 0 +/- 0.2 - <0.001
Sensitization to cockroaches 0.5 0 1.2 0 0.5
IgE level (kU/L), mean +/- SD 0.01 +/- 0.2 - 0 +/- 0.3 - 0.46
All values for categorial or qualitative variables given as percentages. Boldfaced text indicates statistical signiﬁcance.
1AD = atopic dermatitis
2LS = low sensitization
3MS = multiple sensitizations
4FHA = familial history of asthma.
5SD = standard deviation
6Analysis of variance and Chi-2 test when conditions allowed, Kruskal-Wallis and Fischer's exact test otherwise.Boldfaced text indicates statistical
signiﬁcance.
doi:10.1371/journal.pone.0131369.t002
Atopic Dermatitis Phenotypes at Risk of Asthma
PLOSONE | DOI:10.1371/journal.pone.0131369 June 24, 2015 7 / 14
time in spite of a slight decrease in the statistical significance of some variables attested to the
stability of the cluster. Results are summarized in Table 3.
Classification tree and random forest
A classification tree using only 2 variables–sensitization to food allergens and parental history
of asthma–assigned 97% of the children to the appropriate cluster (Fig 2). These two variables
Fig 1. Dendogram for the entire population (n = 214), obtained with a hierarchical bottom-up clustering. Three clusters were apparent. This
agglomerative approach begins with each subject as a separate cluster and merges them into successively larger clusters. By Ward’s linkage, samples were
merged into larger clusters to minimize the within-cluster sum of squares. Cluster 1: “AD with low sensitization”, cluster 2: “AD with multiple sensitizations”,
cluster 3: “ADwith familial history of asthma”.
doi:10.1371/journal.pone.0131369.g001
Table 3. Parameters at the end of the follow-up (6 years).
Outcomes Entire cohort
n = 214
Cluster 1 AD1 with LS2
n = 94
Cluster 2 AD with MS3
n = 84
Cluster 3 AD with FHA4
n = 36
p-
value5
AD remission 47.5 47.1 40.5 64.7 0.06
Asthma at the age of
6
26.6 14.9 36.1 33.3 <0.01
Allergic asthma 21 12.6 30.5 27.3 0.01
All values given as percentages. Boldfaced text indicates statistical signiﬁcance.
1AD = atopic dermatitis
2LS = low sensitization
3MS = multiple sensitizations
4FHA = familial history of asthma.
5Analysis of variance and Chi-2 test when conditions allowed, Kruskal-Wallis and Fischer's exact test otherwise.Boldfaced text indicates statistical
signiﬁcance.
doi:10.1371/journal.pone.0131369.t003
Atopic Dermatitis Phenotypes at Risk of Asthma
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also had the highest random forest score of importance, supporting the relevance of this classi-
fication tree (Fig 3).
Associations of AD phenotypes with risk factors
There was no statistically significant difference between the clusters according to day care
attendance (p = 0.74), socio-economic status (p = 0.5), tobacco smoke exposure (p = 0.07),
furred pet exposure (p = 0.07) or ethnic background (p = 0.24). Children in clusters 2 and 3
were more exposed to tobacco smoke compared to cluster 1 (respectively 41.7 and 44.4% versus
Fig 2. Classification tree for the entire cohort based on two variables. Each subject was assigned to one of the 3 clusters using the tree; 97% of the
subjects were assigned to the appropriate cluster. Tree performance values are given in the table. Cluster 1: “AD with low sensitization”, cluster 2: “AD with
multiple sensitizations”, cluster 3: “AD with familial history of asthma”.
doi:10.1371/journal.pone.0131369.g002
Fig 3. Importance measure (permutation-basedmean decrease accuracy) provided by the random forest analysis. The values are not interpretable
but the ranking is of interest since a high value of the importance measure is associated with a high predictive power. Sensitization is defined by specific IgE
to one or more allergens0.35 kUI/L. Multiple sensitizations were defined as at least two positive specific IgEs to allergens. Serum total IgE level expressed
in kU/L, blood eosinophilia expressed in eosinophils/mm3
doi:10.1371/journal.pone.0131369.g003
Atopic Dermatitis Phenotypes at Risk of Asthma
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27.7%) and to furred pets in cluster 3 compared to clusters 1 and 2 (29.8% versus respectively
19.4% and 16%), without reaching statistical significance (p = 0.07 for both).
Discussion
Our main finding is that we identified 3 phenotypes of early-onset AD: one phenotype mainly
concerning children with low allergenic sensitization, and two with a risk of developing
asthma, one for children who had a parental history of asthma and another for those with mul-
tiple sensitizations to food allergens.
Multiple allergic sensitizations and risk of developing asthma
In high-risk cohorts of wheezing preschool children, sensitization to food allergens and aeroal-
lergens is considered to be a risk factor for developing asthma at the age of 6 [21]. We have pre-
viously described in this cohort that multiple food sensitizations conveys a high risk of
sensitization to aeroallergens at school age [2]. Furthermore, we found that the higher the sum
of specific IgEs, especially IgEs to aeroallergens, the higher the risk of wheeze at school-age [21,
22]. Conversely, in this cohort with early-onset AD, a lower rate of sensitization to allergens
conveyed a lower risk of subsequent asthma. Lack of eosinophilia, low level of total IgE and low
level of sensitization to allergens were mostly present in cluster 1, which seems to convey a
lower risk of asthma at the age of 6. This result is in accordance with previous reports of lack of
eosinophilia as a predictive factor of remission of asthma in wheezing infants [16] and con-
firms a pattern of sensitization, especially if multiple, as a risk factor for asthma at the age of 6
[21]. The prevalence of asthma in the “AD with low sensitization” cluster (cluster 1)
approached the prevalence of asthma in the general population in Western Europe [23]. Con-
versely, asthma prevalence was the highest in the “AD with multiple sensitizations” cluster
(cluster 2) which seems to be closer to the previously described IgE-related AD phenotype [7].
Indeed, this AD phenotype is primarily characterized by high serum IgE levels, specific IgEs to
food allergens or aeroallergens, and is associated with disease severity [24]. This form of AD
may be considered as the initial step of the atopic march [25], as severity and early sensitization
are major prognostic determinants [26, 27]. In this group of patients, immune dysregulation,
including increased serum IgE sensitization to allergens and increased Th2 cytokine expression
in eczematous lesions, may be the underlying pathway leading to the expression of atopic dis-
eases such as allergic asthma [28]. To support this hypothesis, it has been suggested that co-
manifestation of early wheeze and AD does not explain the increased risk of childhood asthma
associated with AD, and that sensitization is the primary confounding factor in this association
[9]. Gene expression seems to be different according to the phenotype, particularly in genes
involved in human keratinocytes, as well as filaggrin expression which is down-regulated in
IgE related AD [24]. Th2 polarization, IgE sensitization immunological pathway, and genetic
background probably explain the increased risk of developing asthma in this AD phenotype,
which can be seen as the atopic march model. However, reducing the pathogenesis of the atopic
march to an “allergic” IgE-mediated disease as has been hypothesized may be exaggerated [8].
Thus, Pinart et al. have shown in a large prospective cohort study that although IgE sensitiza-
tion in independently associated with excess comorbidity of AD, rhinitis and asthma, its pres-
ence accounted for only 38% of comorbidities [29]. The developmental profile of asthma is
probably a far more complex mechanism, and children with early-onset AD who develop
asthma later in life may belong to a particular rare genotype among the atopic diseases [30].
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Parental history as a risk factor for developing asthma in low sensitized
AD phenotype
The relative weight of parental history of asthma has been a matter of debate, although it is
largely accepted as a risk factor for developing asthma in general population. Thus, a personal
history of AD is known to be a more predictive factor for risk of sensitization and asthma in
young children than parental history of asthma in a population of children with recurrent
wheezing [28]. Here, the “AD with familial history of asthma” cluster was associated with a
higher risk of asthma at school-age. This would support our previous results, as a parental his-
tory of asthma has an effect on the development of childhood asthma, independently of allergic
comorbidities [31]. The risk of developing asthma in this cluster may follow an IgE-sensitiza-
tion independent pathway, including innate immunity defects [32]. The link between parental
history of asthma, atopic dermatitis in children and the subsequent risk of developing asthma
for children in this group may indicate an underlying systemic disease of impaired epithelia
[33, 34]. A shared genetic association on innate immunity defects and defective barrier may
explain the subsequent risk of asthma [29].
Strengths and limitations
One strength of our study is that it was a longitudinal prospective cohort in a highly selected
population of infants with early-onset AD explored annually in a standardized manner. Fur-
thermore, all the clinical data were reported by physicians rather than by parents retrospec-
tively. We also developed a simple classification tree with a very good performance value
resulting in 97% of the children being assigned to the appropriate cluster. One limitation could
be the rather small size of the cohort and the absence of a control group. We highlight the fact
that, due to the relatively small sample size, environmental analyses should be taken as purely
exploratory.
However, as mentioned in the introduction, we selected a rare but potentially severe pheno-
type in children at risk of developing asthma i.e., early-onset AD. In this context, the size of
this selected population was greater than the number of patients suffering from this phenotype
if selected from a large birth cohort.
Conclusion
AD should not be seen as a single entity and as such as a systematic input leading to the atopic
march. Indeed, early-onset AD corresponds to various phenotypes which do not follow the
same course. Children with no parental history of asthma and no sensitization have the best
respiratory prognosis. Although there is evidence that highly-sensitized children have a greater
risk of asthma at school-age, atopy definition should not be limited to IgE sensitization which
is insufficient to assess the risk of subsequent asthma. Thus, familial history should be another
risk factor to take in account. Various pathophysiologic mechanisms leading to the clinical
expression of AD associated to asthma could be associated to different genetic polymorphisms.
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